Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Times Interest Earned (2016 - 2025)

Abeona Therapeutics has reported Times Interest Earned over the past 14 years, most recently at -$25.92 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$25.92 for Q4 2025, down 68.2% from a year ago — trailing twelve months through Dec 2025 was -$23.92 (down 56.73% YoY), and the annual figure for FY2025 was -$23.92, down 56.73%.
  • Times Interest Earned for Q4 2025 was -$25.92 at Abeona Therapeutics, up from -$26.66 in the prior quarter.
  • Over the last five years, Times Interest Earned for ABEO hit a ceiling of -$9.14 in Q2 2021 and a floor of -$880.23 in Q4 2021.
  • Median Times Interest Earned over the past 5 years was -$26.29 (2025), compared with a mean of -$90.22.
  • Biggest five-year swings in Times Interest Earned: tumbled 8337.53% in 2021 and later skyrocketed 91.74% in 2022.
  • Abeona Therapeutics' Times Interest Earned stood at -$880.23 in 2021, then skyrocketed by 91.74% to -$72.67 in 2022, then crashed by 66.75% to -$121.18 in 2023, then soared by 87.28% to -$15.41 in 2024, then plummeted by 68.2% to -$25.92 in 2025.
  • The last three reported values for Times Interest Earned were -$25.92 (Q4 2025), -$26.66 (Q3 2025), and -$23.82 (Q2 2025) per Business Quant data.